Link Between Protein Kinase C and Multidrug Resistance in Breast Cancer Cells
Author Information
Author(s): J Budworth, TW Gant, A Gescher
Primary Institution: Medical Research Council Toxicology Unit, University of Leicester
Hypothesis
Is there a link between protein kinase C (PKC) activity and multidrug resistance (mdr) in breast carcinoma cells?
Conclusion
MCF-7/Adr cells lose MDR1 gene expression and PKC activity in a coordinated manner, suggesting a mechanistic link between them.
Supporting Evidence
- MCF-7/Adr cells gradually regained drug sensitivity after doxorubicin was removed.
- P-glycoprotein levels decreased significantly as drug sensitivity increased.
- PKC isoenzyme levels reverted to those seen in wild-type cells by week 24.
Takeaway
The study shows that breast cancer cells can regain sensitivity to a drug called doxorubicin when they are no longer exposed to it, and this is linked to changes in certain proteins.
Methodology
The study measured drug sensitivity, P-glycoprotein levels, PKC isoenzyme levels, and gene copy numbers over 24 weeks after removing doxorubicin from the culture.
Want to read the original?
Access the complete publication on the publisher's website